---

Efficacy of topical tropicamide 1% versus a combination of tropicamide 0.8% and phenylephrine 5% for cycloplegia

---

Original Article

Author Details : Siddesh Kumar H, B Rajendra

Volume : 2, Issue : 4, Year : 2016

Article Page : 373-377

Suggest article by email

Get Permission

---

Abstract

Background: In ophthalmic practice, cycloplegia were required on a regular basis for refraction and fundus evaluation. A well dilated pupil helps the refraction to be carried out more easily and accurately, and also allows a thorough examination of the lens and fundus.
Objective: To compare 1% tropicamide solution with a combination of 0.8% tropicamide and 5% phenylephrine for the degree of cycloplegia and the amount of residual accommodation at 20 minutes after instillation of the drop.
Methods: In this prospective, randomized study, 150 patients who presented to the department of Ophthalmology were evaluated for cycloplegia. They received 1 deop of Tropicamide 1% in one eye and the combination drop in the other eye. The cyclopleiga and residual accommodation were assessed at 20 minutes using the autorefractometer.
Results: In the eyes that received Tropicamide 1%, the mean cycloplegia measured at 20 minutes was 1.12 D and the mean residual accommodation was 1.20 D. In the eyes that received the combination drop, the mean cycloplegia was 1.05 D and the mean residual accommodation was 1.26 D. Though the cyclopegic effect of tropicamide 1% was marginally better than the combination drop, the difference in the two groups was not statistically significant for cycloplegia (p=0.07) or residual accommodation (p=0.15).
Conclusion: A single drop of a combination of 0.8% Tropicamide and 5% Phenylephrine achieves adequate cycloplegia in patients between 11-40 years of age.

Keywords: Cycloplegia, Troplicamide, Phenylephrine, Eye, Residual accommodation

How to cite : Siddesh Kumar H, Rajendra B, Efficacy of topical tropicamide 1% versus a combination of tropicamide 0.8% and phenylephrine 5% for cycloplegia. Indian J Clin Exp Ophthalmol 2016;2(4):373-377

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.